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Advances in ophthalmic plastic and reconstructive surgery con
tinue to be made in the state of Hawaii. A new technique of
dacryocystorhinostomy usthg the endoscope and the pulsed Hol
mium: YAG laser as well as a subconjunctival endoscopic assisted
approach to orbital surgery for orbital decompression is described.
The integrated hydroxyapatite implant replacing the enucleated eye
gives excellent postoperative extraocular motility.
History of Ophthalmic Plastic and Reconstructive
Surgery
Ophthalmic plastic surgery is any surgery that changes the form of
the adnexal tissues of the eye (from the Greek ophthairnos, meaning
eye, and plastos, meaning fonned). Thus, ophthalmic plastic sur
gery includes repair of eyelid malpositions), eyelid and orbital
reconstruction, conjunctivoplasty, cosmetic blepharoplasty, lacri
mal surgery, orbitotomy procedures, and the treatment of orbital
socket deformities.1
Examples of ocular diseases treated by ophthalmic plastic and
reconstructive surgeons are ptosis, eyelid malpositions such as
entropion and ectropion, cancers of the eyelids and ocular surface,
malignant exophthalmos, orbital tumors and blocked tear ducts.
Deformities of the orbital region from congenital defects, trauma,
neoplasms, and/or infectious diseases have afflicted men through
out the ages. Prehistoric skeletal remains reveal deformities that did
not cause death, but ocular disability. The oldest surviving reference
to oculoplastic surgery is a passage from the Code of Hammurabi
(2250 BC) that refers to treatment of an infected lacrimal sac:
“If a physician performs on a patient a deep cut with the
operating knife or if he opens with a knife an (abscess of cavity)
and the eye is lost, the physician’s hands shall be cut off.”
References to the surgical repair of entropion go as far back as
Hippocrates (460-380 BC); the first century Roman philosopher
Celsus (25 BC to 50 BC) believed that reconstruction of mutilated
eyelids was hopeless.2
The development of modern day ophthalmic plastic and recon
structive surgery was started by Byron Smith, an ophthalmologist,
and John Converse, a plastic surgeon, who met during World War
II. They collaborated in the repair of ocular and adnexal injuries
sustained by American soldiers, and described the diagnosis and
treatment of complex naso-orbital fractures.3Subsequent work by
Fox, Callahan, Hughes, and Beard contributed greatly to the devel
opment of this subspecialty.
Ophthalmic plastic and reconstructive surgery has evolved from
these beginnings into a distinct discipline of ophthalmology. Fel
lowship training programs in ophthalmic plastic, lacrimal and
orbital surgery ranging from one to two years are offered by most
large training programs in the United States.
New techniques in laser lacrimal surgery for correcting nasolac
rimal duct obstruction have been developed in Hawaii. Endoscopic
assisted orbital surgery for removal of orbital tumors, repair of
orbital fractures and orbital decompression for Graves’ ophthalm
opathy has been advanced in Hawaii. The first large long term study
of the adjunctive use of Mitomycin C in endoscopic laser assisted
dacryocystorhinostomy has been completed and submitted for
publication.
Endoscopic Laser Assisted Dacryocystorhinos
tomy
Obstruction of the nasolacrimal drainage system may cause
problems ranging from troublesome epiphora to chronic infection,
and formation of a dacryopyocele with abscess formation. Because
the medial angular veins drain into the cavernous sinus, these
infections are considered to be a medical emergency requiring
prompt treatment. (Fig. 1)
The time honored method of correcting a blocked tear duct is an
external dacryocystorhinostomy which has an over 90% success
rate.5 This operation, however, does have disadvantages such as the
skin incision between the bridge of the nose and the medial bound
ary of the eyelid; the potential for significant intraoperative bleed
ing from the medial angular vessels and nasal mucosa; postopera
tive pain requiring pain-suppressants, and the need for approxi
mately a week of recovery time.
The use of the endoscope, with the pulsed high-powered Hol
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Fig 1.—Three year old female child with untreated congenital nasolacrimal duct
obstruction forming lacrimal sac abscess.
Fig 2.—lntraoperative intranasal photograph of osteotomy with silicone stents in
place immediately after endoscopic laser assisted dacryocystorhinostomy.
Fig 5.—Nine year old male status post enucleation of both eyes due to retinoblas
toma with severe orbital atrophy and socket contracture.
Fig 3.—Thirty six year old Hawaiian female with malignant exophthalmos and optic Fig 4.—Same patient after undergoing endoscopic assisted three wall orbital
neuropathy causing severe visual loss in both eyes. decompression to both eyes with recovery of visual acuity bilaterally.
Fig 6.—Same patient after bilateral implantation of hydroxyapatite implants and
fitting of ocular prosthesis.
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mium: YAG laser (Coherent Medical Group, Palo Alto, California)
has resulted in the evolution of intranasal endoscopic laser assisted
dacryocystorhinostomy.6The advantages of this surgical approach
are (1) the absence of a skin incision, (2) significantly less bleeding,
due to the hemostatic properties of the laser, (3) less pain postopera
tively due to the micro-invasive nature of the procedure, and (4)
return to normal activities the day after surgery.
The procedure involves placing a lacrimal light pipe into the
lacrimal sac, and using a videoendoscope attached to a monitor to
visualize the junction of the lacrimal sac and the blocked nasolac
rimal duct. A laser fiber, passed through a handpiece, is used to
create a byspass osteotomy. Silicone stents are then placed through
the osteotomy to keep the opening patent (Fig. 2).
The disadvantages of the procedure are the difficulty learning the
procedure, and the cost of the laser and ancillary equipment. The
societal benefit of earlier return to normal activities, and patient
comfort outweigh these disadvantages. (Akin to the difference
between laparoscopic and open cholecystectomy).
In our series of 250 operations performed in Hawaii, and a follow-
up as long as 5 years, the overall success rate of the procedure is 95%
as compared to a 90% success rate for external dacryocystorhinos
tomy.
Endoscopic Orbital Surgery
In the last decade, the use of the endoscope has become common
place in orthopedic, general, obstetrical, urological, otolaryngologi
cal, thoracic and plastic surgery. Endoscopic surgery is widely
accepted in these surgical specialties because the surgery performed
through a small incision, allows less invasive surgery and quicker
rehabilitation.
Orbital surgery can be performed with the adjunctive use of an
endoscope attached to a videomonitor. When combined with
transcaruncular and subconjunctival approaches to the medial and
inferior orbits, a skin incision can be avoided. Indications for
endoscopic-assisted transcaruncular and subconjunctival approaches
to the orbit include: 1) the repair of medial and floor fractures; 2) the
biopsy and removal of medial and inferior orbital tumors and; 3)
two-wall orbital decompression.
The advantages of endoscopic orbital surgery include a smaller
incision, decreased need for retraction and disruption of delicate
ocular adnexal tissues, better visualization, less bleeding and post
operative pain, and quicker rehabilitation. Teaching new orbital
surgical techniques is facilitated with the use ofthe videoendoscope.
Procedures can be videotaped and used subsequently for educa
tional purposes. Shown in Figure 3 and 4 is a patient before and after
a three wall orbital decompression.
Other uses of the endoscope in orbital surgery include its potential
use in the transnasal endoscopic approach to expose the medial
rectus muscle from the annulus ofZinn to the penetration ofTenon’s
capsule.7A combined transconjunctival and intranasal approach for
decompression of the optic canal has recently been described.8In
ophthalmological surgery, other uses of the endoscope include
cil iary process photocoagulation for end-stage glaucoma9,intraocular
lens implantation’°, and vitreo-retinal surgeryi’
Laser Surgery of the Eyelids and Ocular Adnexa
The use of the CO2 laser in cosmetic and reconstructive eyelid
surgery is gaining increasing acceptance in the field of oculoplastic
surgery. Since the publication on laser eyelid surgery by Baker,’2not
until the advent of ultrapulsed and continuous wave CO2 laser and
the development of laser-safe surgical instruments has this tech
nique become widely used in the United States.
The superpulsed CO2 laser (Coherent Medical Group, Palo Alto,
California) allows for computer controlled vaporization of the
epidermis, papillary, and reticular dermis of the thin eyelid skin for
removal of superficial lesions and rhytids.’3The continuous wave
mode of the CO2 laser allows precise surgical incisions with
excellent hemostasis. The advantage of laser eyelid surgery is early
rehabilitation due to increased hemostasis and decreased postopera
tive swelling and bruising.
The continuous wave CO2 laser in eyelid surgery is used for repair
of ptosis, correction of eyelid malpositions such as entropion and
ectropion, as well as the removal of benign and malignant eyelid
lesions. ThepulsedmodeoftheCO7laseris usedforthe vaporization
of seborrheic keratoses, xanthelasmas, and the cosmetic improve
ment of periocular rhytids.14
The increased cost of the use of the laser is offset by the shorter
recovery phase. Postoperative pain after laser eyelid surgery is
minimal or absent. It is theorized that laser cauterization of sensory
nerves may account for this relative lack of discomfort. Proper
ocular protection of the patient, as well as the operating room staff
is necessary during laser eyelid surgery.
Advances in Enucleation: The Hydroxyapatite
Orbital Implant
An enucleated eye is replaced by placement of an orbital implant
to prevent orbital atrophy and superior sulcus deformity. In the past,
the orbital implants were spheres of glass, polymethlymethcrylate,
silicone, or bone harvested from the iliac crest or rib.
Problems associated with these implants include infection, de
layed or immediate rejection and extrusion, as well as lack of
motility.’5Furthermore, the weight of the prosthesis supported by
the lower eyelid caused laxity and ectropion of the lower eyelid.
Hydroxyapatite is a new orbital implant material which has a
unique interconnected porous matrix derived from marine coral
with a mineral composition similar to bone. This orbital implant
undergoes fibrovascular ingrowth of the patient’s own tissue, be
coming truly integrated and less likely to reject, migrate or extrude.
The hydroxyapatite implant may be used with other surgical tech
niques, more complex than standard enucleation.’6
Since the orbital implant integrates with the patient’s own tissues
the extraocular muscles can be attached directly to the implant,
allowing postoperative motility synchronous with the fellow eye.’7
This property of the integrated hydroxyapatite implant offers
several advantages to the patient undergoing enucleation: 1) Motil
ity of the prosthesis; 2) Less weight bearing by the lower eyelid
which lessens the chances of lower eyelid ectropion; and 3) Less
rejection of the hydroxyapatite implant because of the vascular
ingrowth. Once the hydroxyapatite implant has vascularized, the
implant is drilled and a motility implant sleeve or a motility peg is
attached and coupled to the artificial eye (Fig. 5 and 6).
Vascularization of the implant has to be established before the
artificial eye is attached. Technetium-99m-methylene diphosphonate
(MDP) scintigraphy is a non-invasive method for determining the
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vascularity of the hydroxyapatite ocularimplant. 18 Another method
is the use of a gadolinium DPTA-enhanced MRI with surface coil)9
After the implant has successfully integrated into the orbit, a
motility implant sleeve is drilled into the hydroxyapatite implant
and a peg attached to the prosthesis is connected. This final stage
couples the implant to the prosthesis and allows for extraocular
motility.
The hydroxyapatite implant is popular with oculoplastic surgeons
because of the natural eye movement, resistance to extrusion, rare
complications, and flexibility in fitting the socket. Hydroxyapatite
spheres are contraindicated in those situations other orbital implants
are contraindicated; ie, severe trauma with possible orbital infection
and orbits with poor vascularization and healing qualities, such as
after irradiation, and orbital infection.
Complications of the procedure include infection, conjunctival
dehiscence, and rejection of the implant. Currently, research is
being done on other types of synthetic orbital implants such as a
porous polyethelyene implant with properties similar to the hy
droxyapatite implant.2°
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STRAUB WELCOM ES
Robert V Hollison, Jr, MD
Straub is proud to announce that
Dr. Robert Hollison, well-known
Honolulu physician, is now practic
ing medicine at the new Straub
Manoa Family Health Center.
Dr. Hollison brings extensive medical
expertise to Straub’s integrated,
patient-focused health care system.
And, as Chief of Network Develop-
ment, he will play a key role in help
ing Straub to expand its services
throughout the islands.
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Diplomate, American
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